ALL NEWS

4162 RESULTS

Sort By:

Venusberg Meeting on Neuroinflammation, 2013

Microglia Activation—Venusberg Meeting Questions M1, M2 Designations Inflammatory Crosstalk Between Periphery and Brain Blessing or Curse? Peripheral Cytokines in the Brain Glial Imaging—Amid Slow Progress, EU Project Takes Up Challenge Venusberg Meeting ...

Gladstone Workshop: ApoE4

San Francisco: Tweaking Brain ApoE Reduces Aβ, Symptoms San Francisco: GABA Neurons Blamed for Memory Loss in ApoE Mice Considering the dramatic impact of its E4 allelic variant on Alzheimer’s disease risk, apolipoprotein E arguably has drawn scant ...

Frontotemporal Dementia Treatment: 2011 Study Group Meeting

Las Vegas: Lou Ruvo Center Pioneers New Approach to Clinical Trials Las Vegas: Are Frontotemporal Dementia Models Fit for Pharma? Las Vegas: Can Collaboration Speed Drug Discovery for FTD? The Lou Ruvo Center for Brain Health opened in Las Vegas in 2009 ...

American Academy of Neurology: 2013 Annual Meeting

Quick-and-Early IVIG Therapy: Hints of Promise Anti-Amyloid Results Show Modest Benefits, Mild Side Effects Wrapping Up Enrollment, ADNI 2, PPMI Focus on Earlier Disease Drug Data Dash at AAN Annual Conference The ANN conference in San Diego covered such ...

American Academy of Neurology: 2014 Annual Meeting

Mesulam Awarded Potamkin Prize Three’s Company: Florbetaben Approved, Excludes AD Diagnosis PET Tracers Enlighten at Neurology Conference Blood Patterns: Prowling for Alzheimer’s Clues in Plasma Tau imaging of patients with different kinds of dementia and ...

Alzheimer’s Prevention Initiative Workshop: Colombian Families

Colombians Come to Fore in Alzheimer’s Research, Mass Media A Neurologist’s Devotion Puts Familial AD Research Onto New Plane Detecting Familial AD Ever Earlier: Subtle Memory Signs 15 Years Before Scientists and Regulators Discuss Preclinical AD Trials ...

ACT-AD FDA/AD Allies Meeting, 2012

Combination Drug Trials: Time to Open a New Front in AD? Combination Trials: FDA Puts Flesh on Bones of Draft Guidance Combination Trials: Companies Can Play Well in One Sandbox Building a Roadmap for Shared Combination Drug Trials ACT-AD FDA/AD Allies ...

Global Consortium for the Standardization of CSF Biomarkers

CSF Markers: Goodbye, Research Use Only; Hello, Clinical Metrology, Certification Heavies Take CSF Tests Under Their Wings The Global Consortium for the Standardization of CSF Biomarkers met in Vancouver, Canada, on 14 July 2012 to assess moves on two ...

Eibsee Meeting on Cellular Mechanisms of Alzheimer’s Disease, 2008

Eibsee: 8th Gathering of German-International Alzheimer’s Researchers Eibsee: Keynote on Anti-amyloid Drugs, Prevention Eibsee: Still Game for γ—Sparring With a Formidable Enzyme Eibsee: Channel Vanishes in Sharper Image Eibsee: Soft Cocktail—In Search of ...

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE OF NEWS
DISEASE
TOPIC
BIOMOLECULE